Lila is a seasoned life sciences corporate lawyer who has over 20 years of experience representing life sciences companies in their discovery, development and marketing of pharmaceutical, vaccine, medical device, diagnostic and digital health products. Leveraging her deep scientific background, she specializes in licensing transactions involving complex intellectual property, business, operational and legal issues, including strategic partnerships and platform discovery and option deals. In addition to her long-established practice in the US, Lila is a lead practitioner in cross-border licensing transactions, having concluded more than 40 transactions involving Asian biotechnology companies since 2015.